Moyamoya Disease: When Is Endovascular Treatment Considered?

Moyamoya disease is a rare condition in which major brain arteries gradually narrow, increasing the risk of stroke or bleeding. Endovascular treatment may play a limited but important role in selected cases, although surgery remains the main long-term treatment for most patients.

Overview

Moyamoya disease is a chronic cerebrovascular disorder in which the internal carotid arteries or their main branches gradually become narrowed or blocked near the base of the brain. As blood flow decreases, the brain tries to compensate by forming a network of tiny collateral vessels. On angiography, these small vessels can look like a hazy puff of smoke, which is the meaning of the Japanese word “moyamoya.”

This condition can affect both children and adults. In children, it often presents with reduced blood flow to the brain, which may cause transient ischemic attacks or strokes. In adults, it may also present with brain hemorrhage if fragile collateral vessels rupture. Some people are diagnosed after symptoms begin, while others are found during evaluation for headaches, family history, or an unrelated imaging test.

The main goal of treatment is to protect the brain by improving or supporting blood flow and reducing the risk of future stroke. Surgery is the best-established treatment for many patients. Endovascular treatment, which uses catheters placed inside blood vessels, may be considered in certain circumstances, but it is not usually the primary long-term treatment for the underlying arterial narrowing in moyamoya disease.

Symptoms and Possible Complications

Symptoms of moyamoya disease vary depending on age, the degree of narrowing, and whether the main problem is reduced blood flow or bleeding. Some episodes are brief and reversible, while others may leave lasting neurological effects. Symptoms can develop gradually or appear suddenly.

Common symptoms may include weakness on one side of the body, speech difficulty, numbness, visual changes, headaches, dizziness, seizures, or short episodes that resemble mini-strokes. In children, symptoms may be triggered by crying, fever, dehydration, or hyperventilation, all of which can reduce brain blood flow further. In adults, a first sign may sometimes be intracranial bleeding.

Complications are mainly related to stroke. These can include problems with movement, learning, memory, speech, or daily function. Recurrent ischemic events may occur if the brain is not receiving enough blood, and fragile collateral vessels may bleed. Because these outcomes can affect quality of life, early diagnosis and specialist follow-up are important.

• Transient ischemic attacks
• Ischemic stroke
• Hemorrhagic stroke
• Seizures
• Cognitive or developmental difficulties

Causes and Risk Factors

The exact cause of moyamoya disease is not fully understood. It is considered a rare vascular disorder, and genetic factors appear to play a role in some patients. It can occur on its own, which is called moyamoya disease, or together with another condition, sometimes referred to as moyamoya syndrome.

Risk may be higher in people with a family history of the condition and in certain populations where it is seen more often. Moyamoya-like changes can also be associated with conditions such as Down syndrome, neurofibromatosis type 1, sickle cell disease, prior radiation to the head, or other vascular disorders. Not everyone with these risk factors will develop moyamoya, but they may prompt closer evaluation if symptoms appear.

It is important to distinguish moyamoya disease from other causes of brain artery narrowing, such as atherosclerosis or inflammatory vessel disease. This is one reason why specialist imaging and clinical assessment matter. The pattern of narrowing, collateral vessel formation, age, symptoms, and medical history all help guide the diagnosis and treatment plan.

How Moyamoya Disease Is Diagnosed

Diagnosis usually begins with a neurological evaluation and brain imaging. Doctors often use MRI and MRA to look for signs of stroke, reduced blood flow, and characteristic narrowing of the arteries. CT and CTA may also be used, especially in urgent settings or when bleeding is suspected.

A cerebral angiogram is often the most detailed test for confirming the diagnosis and understanding the blood vessel anatomy. During this procedure, contrast dye is injected through a catheter so the arteries can be seen clearly. This helps identify the severity of narrowing, the extent of collateral vessels, and whether aneurysms or other vascular changes are present. In some cases, blood flow studies are added to assess how well the brain is being supplied.

Doctors may also order blood tests or other studies to look for associated conditions and to rule out disorders that can mimic moyamoya. Because management decisions can be complex, many patients benefit from review by a multidisciplinary team that may include neurologists, neurosurgeons, neuroradiologists, and interventional specialists. When advanced vascular imaging is needed, cerebral angiography can provide essential detail for treatment planning.

When Is Endovascular Treatment Considered?

For most patients, endovascular treatment is not the standard long-term solution for the progressive arterial narrowing that defines moyamoya disease. This is because angioplasty or stenting of the narrowed arteries has limited durability in this setting and may carry significant risks, including vessel injury, re-narrowing, or stroke. In general, surgical revascularization remains the preferred strategy for improving blood flow over time.

Even so, endovascular treatment may be considered in selected situations. One example is when moyamoya is associated with an aneurysm, especially if the aneurysm has ruptured or is considered at high risk of bleeding. In that circumstance, catheter-based treatment may help secure the aneurysm. Another possible use is emergency or highly individualized management of a specific vascular lesion, always after careful review by experienced specialists.

In rare cases, angioplasty or stenting may be discussed if there is uncertainty about the diagnosis, if the arterial narrowing is related to another process rather than classic moyamoya disease, or if a patient has an unusual anatomy that changes the balance of risks and benefits. These decisions are highly case-specific. The aim is not to replace established moyamoya surgery when surgery is appropriate, but to address a clearly defined vascular problem that may benefit from an endovascular approach.

Patients and families often ask whether a less invasive catheter procedure can avoid surgery. While that question is understandable, the answer is usually that endovascular therapy has a limited role in true moyamoya disease itself. If an aneurysm or another treatable vascular abnormality is found, doctors may discuss options such as aneurysm coiling or, in carefully selected cases, carotid artery stenting if the narrowing pattern suggests a different diagnosis or overlapping vascular disease.

Treatment Options Beyond Endovascular Care

The mainstay of treatment for symptomatic moyamoya disease is revascularization surgery. These operations are designed to improve blood supply to the brain, either by directly connecting a scalp artery to a brain artery or by placing vascularized tissue near the brain surface so new blood vessels can grow over time. The choice of technique depends on the patient’s age, vessel anatomy, symptoms, and surgical expertise.

Medicines may also be used as part of overall care. Depending on the clinical situation, doctors may recommend antiplatelet therapy, seizure treatment, blood pressure management, or other supportive measures. Medications do not reverse the underlying vessel narrowing, but they can help reduce complications or manage related symptoms. It is important for treatment to be individualized, especially after a stroke or bleeding event.

Rehabilitation may be needed if a patient has weakness, speech changes, or cognitive effects after a stroke. Physical, occupational, and speech therapy can support recovery and daily function. Some people may also need long-term neurological follow-up and repeat imaging to monitor circulation and assess ongoing risk. Patients who have related cerebrovascular conditions may also hear terms such as brain aneurysm or stroke during evaluation and follow-up.

Prevention, Self-care, and Follow-up

There is no known way to prevent moyamoya disease itself, but careful self-care can help lower the chance of triggering ischemic symptoms and support overall brain health. Good hydration is often encouraged, especially in children who may be more sensitive to drops in blood flow. Doctors may also advise avoiding situations that lead to prolonged dehydration or excessive hyperventilation.

People with moyamoya should follow their treatment plan closely and attend regular follow-up visits. Ongoing assessment helps doctors watch for new symptoms, evaluate blood flow, and decide whether additional treatment is needed. Families should also learn the warning signs of stroke and know when to seek urgent medical care.

General vascular health remains important. This includes controlling blood pressure, avoiding smoking, and managing any associated medical conditions. Near the end of the care pathway, some international patients may seek treatment at centers with coordinated expertise; Acibadem International’s multidisciplinary specialists and JCI-accredited hospitals diagnose and treat moyamoya disease and related cerebrovascular conditions for international patients.

When to See a Doctor

Any sudden neurological symptom requires urgent medical attention. This includes weakness, facial drooping, difficulty speaking, severe sudden headache, seizures, confusion, vision loss, or trouble walking. Even if symptoms go away quickly, they may represent a transient ischemic attack and should not be ignored.

A non-urgent specialist evaluation is also important for recurring headaches with neurological symptoms, repeated fainting-like episodes, unexplained seizures, or a family history of moyamoya disease. Children who have brief episodes of weakness, speech difficulty, or symptoms triggered by crying or exertion should be assessed promptly.

Early evaluation can make a meaningful difference because the risk of further stroke may be reduced with appropriate treatment and monitoring. A neurologist, neurosurgeon, or cerebrovascular team can explain whether surgery, observation, medication, or a selective endovascular procedure is most suitable for the individual case.

Frequently asked questions

Is endovascular treatment the main treatment for moyamoya disease?

Usually not. For most patients, surgery to improve blood flow is the standard long-term treatment, while endovascular treatment is reserved for selected situations such as associated aneurysms or unusual vascular findings.

Why is stenting not commonly used for moyamoya disease?

The narrowed arteries in moyamoya disease behave differently from arteries narrowed by common atherosclerosis. Stenting or angioplasty may not provide durable benefit and can carry risks such as vessel injury, re-narrowing, or stroke.

Can moyamoya disease cause both stroke and bleeding?

Yes. Moyamoya disease can reduce blood flow and cause ischemic stroke, and the fragile collateral vessels can also bleed, especially in some adults. The exact pattern varies from person to person.

How do doctors confirm moyamoya disease?

Doctors usually use brain imaging such as MRI, MRA, CT, or CTA, and often confirm the diagnosis with cerebral angiography. These tests help show the narrowed arteries, collateral vessels, and any related aneurysms or prior strokes.

Is moyamoya disease hereditary?

It can be in some families, and genetic factors are believed to contribute in certain patients. However, not every person with moyamoya has a family history, and the condition may also occur with other medical disorders.

What should a person with moyamoya disease avoid?

Patients should follow their doctor’s advice, but staying well hydrated and avoiding triggers that may reduce brain blood flow can be helpful. They should also avoid smoking and seek urgent help for any sudden neurological symptoms.

References

• American Heart Association
• National Institute of Neurological Disorders and Stroke
• National Organization for Rare Disorders
• European Stroke Organisation
• Radiological Society of North America

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.